JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB242313

Anti-TAZ antibody [CL0371]

4

(2 Reviews)

|

(18 Publications)

Mouse Monoclonal TAZ antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 18 publications. Immunogen corresponding to Recombinant Fragment Protein within Human WWTR1 aa 1-200.

View Alternative Names

TAZ, WWTR1, WW domain-containing transcription regulator protein 1, Transcriptional coactivator with PDZ-binding motif

8 Images
Immunocytochemistry/ Immunofluorescence - Anti-TAZ antibody [CL0371] (AB242313)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-TAZ antibody [CL0371] (AB242313)

Immunocytochemistry/Immunofluorescence analysis of SK-MEL cells labeling TAZ using ab242313 at 4 μg/ml (green). Microtubules are visualized in red.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAZ antibody [CL0371] (AB242313)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAZ antibody [CL0371] (AB242313)

Formalin-fixed, paraffin-embedded human breast cancer tissue stained for TAZ with ab242313 at a 1 : 50 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAZ antibody [CL0371] (AB242313)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAZ antibody [CL0371] (AB242313)

Formalin-fixed, paraffin-embedded human placenta tissue stained for TAZ with ab242313 at a 1 : 50 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAZ antibody [CL0371] (AB242313)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAZ antibody [CL0371] (AB242313)

Formalin-fixed, paraffin-embedded human kidney tissue stained for TAZ with ab242313 at a 1 : 50 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAZ antibody [CL0371] (AB242313)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAZ antibody [CL0371] (AB242313)

Negative control :

Formalin-fixed, paraffin-embedded human lymph node tissue stained for TAZ with ab242313 at a 1 : 50 dilution in immunohistochemical analysis.

Western blot - Anti-TAZ antibody [CL0371] (AB242313)
  • WB

Lab

Western blot - Anti-TAZ antibody [CL0371] (AB242313)

False colour image of Western blot : Anti-TAZ antibody [CL0371] staining at 1 ug/ml, shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab242313 was shown to bind specifically to TAZ. A band was observed at 52 kDa in wild-type HeLa cell lysates with no signal observed at this size in WWTR1 knockout cell line ab281598 (knockout cell lysate ab282950). To generate this image, wild-type and WWTR1 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.

All lanes:

Western blot - Anti-TAZ antibody [CL0371] (ab242313) at 1 µg/mL

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

WWTR1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human WWTR1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-wwtr1-knockout-hela-cell-line-ab281598'>ab281598</a>)

Lane 3:

A549 cell lysate at 20 µg

Lane 4:

K562 cell lysate at 20 µg

Predicted band size: 44 kDa

Observed band size: 52 kDa

false

Western blot - Anti-TAZ antibody [CL0371] (AB242313)
  • WB

Supplier Data

Western blot - Anti-TAZ antibody [CL0371] (AB242313)

Loading control : anti-PPIB.

All lanes:

Western blot - Anti-TAZ antibody [CL0371] (ab242313) at 1 µg/mL

Lane 1:

Control siRNA transfected EFO-21 cell lysate

Lane 2:

siRNA#1 transfected EFO-21 cell lysate

Lane 3:

siRNA#2 transfected EFO-21 cell lysate

Predicted band size: 44 kDa

false

Western blot - Anti-TAZ antibody [CL0371] (AB242313)
  • WB

Supplier Data

Western blot - Anti-TAZ antibody [CL0371] (AB242313)

All lanes:

Western blot - Anti-TAZ antibody [CL0371] (ab242313) at 1 µg/mL

All lanes:

U-251 MG (Human brain glioma cell line) cell lysate

Predicted band size: 44 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

CL0371

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

ICC/IF, IHC-P, WB

applications

Immunogen

Recombinant Fragment Protein within Human WWTR1 aa 1-200. The exact immunogen used to generate this antibody is proprietary information.

Q9GZV5

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/200", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "2-10 µg/mL", "ICCIF-species-notes": "<p>Fixation/Permeabilization: PFA/Triton X-100.</p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Purified from TCS.
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TAZ also known as WWTR1 (WW Domain-Containing Transcription Regulator 1) acts as a transcriptional co-activator in cells. TAZ has a molecular mass of approximately 45 kDa. This protein appears in various tissues including the lung kidney brain and heart. TAZ interacts with other transcription factors to influence gene expression playing a role in cellular signaling and development.
Biological function summary

TAZ works as a part of the Hippo signaling pathway regulating cell growth proliferation and apoptosis. It changes cellular responses through interactions with other proteins such as TEAD transcription factors. TAZ can act within the cytoplasm or the nucleus changing its location in the cell based on physiological signals. It operates independently as well as in concert with other molecules assisting in maintaining tissue homeostasis and regeneration.

Pathways

TAZ functions as an essential element of the Hippo pathway which controls organ size and suppresses cancer. It plays significant roles in the PI3K-AKT signaling pathway coordinating with YAP (Yes-associated protein) a well-known partner in these pathways. TAZ and YAP together influence transcriptional outcomes for numerous genes adjusting to the needs of various cellular contexts which affect cell behavior significantly.

TAZ associates with cancer and fibrosis. In many cancers TAZ exhibits high activity often linked with poor prognosis due to its role in promoting cell proliferation and survival. TAZ interacts with beta-catenin in cancer contexts influencing signaling that drives cancer progression. In fibrosis aberrant TAZ signaling leads to excessive tissue scarring working alongside CTGF (Connective Tissue Growth Factor) to support this pathological development.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcriptional coactivator which acts as a downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed : 11118213, PubMed : 18227151, PubMed : 23911299). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed : 18227151). WWTR1 enhances PAX8 and NKX2-1/TTF1-dependent gene activation (PubMed : 19010321). In conjunction with YAP1, involved in the regulation of TGFB1-dependent SMAD2 and SMAD3 nuclear accumulation (PubMed : 18568018). Plays a key role in coupling SMADs to the transcriptional machinery such as the mediator complex (PubMed : 18568018). Regulates embryonic stem-cell self-renewal, promotes cell proliferation and epithelial-mesenchymal transition (PubMed : 18227151, PubMed : 18568018).
See full target information WWTR1

Publications (18)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:1751 PubMed39966435

2025

A postzygotic GNA13 variant upregulates the RHOA/ROCK pathway and alters melanocyte function in a mosaic skin hypopigmentation syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Rana El Masri,Alberto Iannuzzo,Paul Kuentz,Rachida Tacine,Marie Vincent,Sébastien Barbarot,Fanny Morice-Picard,Franck Boralevi,Naia Oillarburu,Juliette Mazereeuw-Hautier,Yannis Duffourd,Laurence Faivre,Arthur Sorlin,Pierre Vabres,Jérôme Delon

iScience 27:111133 PubMed39524367

2024

Intra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981.

Applications

Unspecified application

Species

Unspecified reactive species

Richa Sharma,Shagun Sharma,Pratik Shriwas,Labdhi Mehta,An H Vu,Janna K Mouw,Junghui Koo,Chunzi Huang,Veronika Y Matsuk,Carol Tucker-Burden,Gregory Joseph,Madhusmita Behera,Shi-Yong Sun,Melissa A Roy,Melissa Gilbert-Ross,Ticiana Leal,Adam I Marcus,Mala Shanmugam

Discover oncology 15:73 PubMed38478152

2024

GALNT2 targeted by miR-139-5p promotes proliferation of clear cell renal cell carcinoma via inhibition of LATS2 activation.

Applications

Unspecified application

Species

Unspecified reactive species

Haisheng Yi,Lingyun Liu,Jingshun Zhang,Kaimin Guo,Yin Cao,Penghao Sun,Hongliang Wang

Molecular and cellular biology 44:27-42 PubMed38270135

2024

A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63.

Applications

Unspecified application

Species

Unspecified reactive species

Ana Maria Low-Calle,Hana Ghoneima,Nicholas Ortega,Adriana M Cuibus,Chen Katz,Carol Prives,Ron Prywes

Biomedicines 11: PubMed37509515

2023

Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Kostas Palamaris,Georgia Levidou,Katerina Kordali,Christos Masaoutis,Dimitra Rontogianni,Stamatios Theocharis

Journal of biomedical materials research. Part A 111:1781-1797 PubMed37494632

2023

Elastic modulus of hydrogel regulates osteogenic differentiation via liquid-liquid phase separation of YAP.

Applications

Unspecified application

Species

Unspecified reactive species

Kuang Tan,Qiaolin Yang,Yineng Han,Ziyao Zhuang,Yi Zhao,KunYao Guo,Anqi Tan,Yunfei Zheng,Weiran Li

International journal of biological sciences 19:2319-2332 PubMed37215988

2023

The deubiquitinase UCHL1 negatively controls osteoclastogenesis by regulating TAZ/NFATC1 signalling.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenhua Feng,Siyue Tao,Zhaobo Huang,Bingjie Zheng,Xiangxi Kong,Yufeng Xiang,Qibin Zhang,Haixin Song,Zhikun Xu,Xiaoan Wei,Fengdong Zhao,Jian Chen

Nature communications 14:238 PubMed36646707

2023

Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation.

Applications

Unspecified application

Species

Unspecified reactive species

Xinwei Liu,Yingying Ye,Liling Zhu,Xiaoyun Xiao,Boxuan Zhou,Yuanting Gu,Hang Si,Huixin Liang,Mingzhu Liu,Jiaqian Li,Qiongchao Jiang,Jiang Li,Shubin Yu,Ruiying Ma,Shicheng Su,Jian-You Liao,Qiyi Zhao

International journal of molecular sciences 23: PubMed36498853

2022

Sphingosine Kinase 1 Deficiency in Smooth Muscle Cells Protects against Hypoxia-Mediated Pulmonary Hypertension via YAP1 Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Jiwang Chen,Angelia Lockett,Shuangping Zhao,Long Shuang Huang,Yifan Wang,Weiwen Wu,Ming Tang,Shahzaib Haider,Daniela Velez Rendon,Raheel Khan,Bing Liu,Nicholas Felesena,Justin R Sysol,Daniela Valdez-Jasso,Haiyang Tang,Yang Bai,Viswanathan Natarajan,Roberto F Machado

Oral diseases 30:149-162 PubMed35951471

2022

Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study.

Applications

Unspecified application

Species

Unspecified reactive species

Juan P Rodrigo,Tania Rodríguez-Santamarta,Daniela Corte,Vanessa García-de-la-Fuente,Nerea Rodríguez-Torres,Paloma Lequerica-Fernández,Corina Lorz,Juana M García-Pedrero,Juan C de Vicente
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com